Contributions of estrogen to ER-negative breast tumor growth
- 16 October 2006
- journal article
- review article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 102 (1-5) , 71-78
- https://doi.org/10.1016/j.jsbmb.2006.09.025
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- THE CAPACITY OF BREAST TISSUE TO ACCUMULATE OESTRADIOL-17β IN VITROActa Pathologica Microbiologica Scandinavica, 2009
- Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and MetastasisPublished by Elsevier ,2006
- A putative human breast stem cell population is enriched for steroid receptor-positive cellsDevelopmental Biology, 2004
- A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast CancerNew England Journal of Medicine, 2004
- A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast CancerNew England Journal of Medicine, 2003
- Overview of the main outcomes in breast-cancer prevention trialsThe Lancet, 2003
- Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 SitesScience, 1997
- Cloning of a novel receptor expressed in rat prostate and ovary.Proceedings of the National Academy of Sciences, 1996
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 womenThe Lancet, 1992
- Status of adjuvant therapy. Results of the national surgical adjuvant breast project studies on oophorectomy, postoperative radiation therapy, and chemotherapy.Other comments concerning clinical trialsCancer, 1971